Please select your region.

Hello, we’re human HUMN,

nice to meet you.

Curiosity, Ingenuity, Passion & Excellence

The strongest medicine that exists for a human being is another human being and thus our organization stands by the values shared by all of our people. We like to believe that we have put together something extraordinary; a rare group of seasoned and successful people at the top of their careers to bring about a new vision, revolutionary products and ethical change. We know that making a difference in the world requires the very best intentions and actions. It requires real human connection; the ability to feel the heart of another. This is at the very core of who we are and what we do. It is what makes us HUMN.

Executive Management Team

Blair J. McInnes

Founder and Chairman of the Board

Art Pemberton

President and Chief Operating Officer

Alan Refkin

Chief Strategic Officer

Brian Herron

Managing Director, UK

Executive Management Team

Blair J. McInnes

Founder and Chairman of the Board

Art Pemberton

President and Chief Operating Officer

Alan Refkin

Chief Strategic Officer

Brian Herron

Managing Director, UK

Management

Rodger Lundon

Manager Client Services

Chris Moss

Director of Special Projects

Michael van der Horn

Manager Information Technology

Rowan Hamilton D.Phyt. DTCM

Director of Research and Education

Greg Herron

Executive Director UK

Brigitte Mundy

Manager Distribution Centre

Blabbly LTD

Brand Marketing Management

Management

Rodger Lundon

Manager Client Services

Chris Moss

Director of Special Projects

Michael van der Horn

Manager Information Technology

Rowan Hamilton D.Phyt. DTCM

Director of Research and Education

Greg Herron

Executive Director UK

Brigitte Mundy

Manager Distribution Centre

Blabbly LTD

Brand Marketing Management

Board of Directors

Blair J. McInnes

Founder and Chairman of the Board

Art Pemberton

President and Chief Operating Officer

Brian Herron

Managing Director, UK

Connie Clerici

Director Designate

Gail Halko

Director Designate

Board of Directors

Blair J. McInnes

Founder and Chairman of the Board

Art Pemberton

President and Chief Operating Officer

Brian Herron

Managing Director, UK

Connie Clerici

Director Designate

Gail Halko

Director Designate

Technical Board

Gail Halko

Chief Executive Officer of SpiritRx Services

Adam Topp

Technical Board

Ken Carroll

Director Designate

Bev Wilson

Technical Board

Bev Wilson

Technical Board

Technical Board

Ken Carroll

Director Designate

Finding your passion isn’t just about finding a career and money. It is about learning to relinquish the ego and finding your authentic self. Although we are in the business of helping people, we set forth a culture where our people do not bury their personal needs beneath the needs of others. We understand that balance.

Blair McInnes
/
Founder and Chair of the Board

Where HUMN Developments are Emerging

Make Possibilities Real.

Blair J. McInnes


Founder and Chairman of the Board

Blair McInnes has as spent several decades founding, running, and investing in companies that addressed an unfulfilled need with a clear and executable vision of their market niche. As president of a Canadian company, he expanded its market into the United States where it established itself as a multi-million-dollar enterprise. McInnes also negotiated the acquisition of a Canadian IT company and brought it into the US public market to expand both the company’s access to capital as well as its shareholder value. Eight years ago, he saw what he believed to be a unique opportunity in the pharmaceutical marketplace and provided the seed capital to found Humn Pharmaceuticals. Fueled by his belief that everyone deserves affordable natural products that are safe and perform as intended, he assembled experienced management and research teams and focused the company to develop formulations that filled this void, eventually expanding these products beyond Canada and into the United States and Europe. Working with his research teams, Blair continues to help address the development of products that satisfy the demand for products in areas lacking solutions. In parallel, he coordinates with his sales team to establish distribution channels for these products.

Art Pemberton


President And Chief Operating Officer

Art Pemberton has a successful 30+ year record of strategic, executive / senior management, and consulting roles with both private and public international corporations. He’s been regarded as the driving force in the creation of dominant and vertically integrated organizations for two of Canada's leading companies which marketed their products internationally. As the president, CEO, and board member of a $500 million manufacturing, wholesale, and retail conglomerate with over 5,000 employees, Art was involved in the retail, distribution and manufacturing aspects of the business with strategic input to operations, information technology, human resources, legal, and finance thereby substantially driving sales and profitability. He is also a recognized expert in mergers, acquisitions, and turnarounds. As the President / COO of a retail chain with five operating divisions within North America, Art negotiated the acquisition of a retail chain out of bankruptcy and within three months restructured the company to such an extent that it was able to reopen sixty-four stores on a single day. The speed of implementation, along with the financial and business expertise displayed in this restructuring, enabled the acquiring company to enhance its profitability thereby increasing profits, through both savings and revenue, by millions annually. Art is focused on overseeing the strategic aspects of product development, expanding Humn Pharmaceuticals through mergers and acquisitions, and creating the infrastructure that will allow it to function as a public company.

Alan Refkin


Chief Strategic Officer

Alan Refkin is the founder of Thornhill Capital, a global forensic due diligence firm that provides an array of world-class consulting, financial, accounting, compliance, risk management, expert witness testimony, and related services to public and private companies as well as financial institutions. Alan started his career on Wall Street in 1976 and eventually became a Senior Vice President of Drexel, Burnham, Lambert - at the time one of the world’s largest banking firms. He’s an expert on conducting business in Asia, having spoken at China’s People’s Congress and many government functions within China on the intricacies of cross-border mergers and acquisitions. His experience in international finance has enabled him to negotiate transactions in many countries - including France, Germany, Switzerland, and China. Alan is the acclaimed author of several award-winning business books including: “How to do Due Diligence on Chinese Companies.” His financial, business and negotiating acumen complements the expertise of management to help propel the company into international markets and enhance shareholder value.

Brian Herron


Managing Director, UK 

Has over 30 years of experience in distribution logistics within the pharmaceutical and health products industry, primarily in Europe. His responsibilities entailed fleet management, warehousing, shipping, customer relationship management. Brian brings more than three decades of experience to Humn Pharmaceuticals with a focus on creating a seamless and dynamic customer distribution network.

Blair J. McInnes


Founder and Chairman of the Board

Blair McInnes has as spent several decades founding, running, and investing in companies that addressed an unfulfilled need with a clear and executable vision of their market niche. As president of a Canadian company, he expanded its market into the United States where it established itself as a multi-million-dollar enterprise. McInnes also negotiated the acquisition of a Canadian IT company and brought it into the US public market to expand both the company’s access to capital as well as its shareholder value. Eight years ago, he saw what he believed to be a unique opportunity in the pharmaceutical marketplace and provided the seed capital to found Humn Pharmaceuticals. Fueled by his belief that everyone deserves affordable natural products that are safe and perform as intended, he assembled experienced management and research teams and focused the company to develop formulations that filled this void, eventually expanding these products beyond Canada and into the United States and Europe. Working with his research teams, Blair continues to help address the development of products that satisfy the demand for products in areas lacking solutions. In parallel, he coordinates with his sales team to establish distribution channels for these products.

Art Pemberton


President And Chief Operating Officer

Art Pemberton has a successful 30+ year record of strategic, executive / senior management, and consulting roles with both private and public international corporations. He’s been regarded as the driving force in the creation of dominant and vertically integrated organizations for two of Canada's leading companies which marketed their products internationally. As the president, CEO, and board member of a $500 million manufacturing, wholesale, and retail conglomerate with over 5,000 employees, Art was involved in the retail, distribution and manufacturing aspects of the business with strategic input to operations, information technology, human resources, legal, and finance thereby substantially driving sales and profitability. He is also a recognized expert in mergers, acquisitions, and turnarounds. As the President / COO of a retail chain with five operating divisions within North America, Art negotiated the acquisition of a retail chain out of bankruptcy and within three months restructured the company to such an extent that it was able to reopen sixty-four stores on a single day. The speed of implementation, along with the financial and business expertise displayed in this restructuring, enabled the acquiring company to enhance its profitability thereby increasing profits, through both savings and revenue, by millions annually. Art is focused on overseeing the strategic aspects of product development, expanding Humn Pharmaceuticals through mergers and acquisitions, and creating the infrastructure that will allow it to function as a public company.

Alan Refkin


Chief Strategic Officer

Alan Refkin is the founder of Thornhill Capital, a global forensic due diligence firm that provides an array of world-class consulting, financial, accounting, compliance, risk management, expert witness testimony, and related services to public and private companies as well as financial institutions. Alan started his career on Wall Street in 1976 and eventually became a Senior Vice President of Drexel, Burnham, Lambert - at the time one of the world’s largest banking firms. He’s an expert on conducting business in Asia, having spoken at China’s People’s Congress and many government functions within China on the intricacies of cross-border mergers and acquisitions. His experience in international finance has enabled him to negotiate transactions in many countries - including France, Germany, Switzerland, and China. Alan is the acclaimed author of several award-winning business books including: “How to do Due Diligence on Chinese Companies.” His financial, business and negotiating acumen complements the expertise of management to help propel the company into international markets and enhance shareholder value.

Brian Herron


Managing Director, UK 

Has over 30 years of experience in distribution logistics within the pharmaceutical and health products industry, primarily in Europe. His responsibilities entailed fleet management, warehousing, shipping, customer relationship management. Brian brings more than three decades of experience to Humn Pharmaceuticals with a focus on creating a seamless and dynamic customer distribution network.

Rodger Lundon


Manager Client Services

Has an extensive background in retailing and business administration including inventory management, human resources, supply chain functions in addition to back-office administration systems.

Chris Moss


Director of Special Projects

Chris Moss

Chris Moss is an accomplished medical, pharma, and surgical representative with a longstanding track record of success including recognition for highest national sales and profit performance. Chris has developed and maintained an expansive network over his 40-year tenure with contacts and working relationships across the medical, surgical, and pharma fields, including a diverse network of customers and end-users, medical and surgical specialists, buyers, managers, key decision-makers in buying groups and health regulatory and legislative authorities.

His exceptional knowledge of a wide spectrum of products in surgical, medical, and OTC Pharma fields, including product applications and functions have won Chris numerous sales distinctions and top Canadian performer awards, attaining "lion's share" of his market. Chris has always put the customer first and foremost, and after many years of problem-solving, he became the trusted advisor within his territory. He is a strong believer in collaboration and teamwork; a foundation that was built on his athletic background tracing back to highschool and university, which in turn has helped him develop strong bonds with his working associates over the years. HUMN is now his team and with Chris' long-standing reputation, distinguished sales proficiencies and capacity to network and to bring people together has and will continue to add value to the dynamic management group at Humn Pharmaceuticals

Michael van der Horn


Manager Information Technology

Owner and Director of an IT Services company providing both software solutions and management services. In the past 15 years, he has provided IT services in the healthcare, finance and insurance industries.

Rowan Hamilton D.Phyt. DTCM


Director of Research and Education 

Rowan Hamilton is a Medical Herbalist and Doctor of TCM, having studied in England and China at the Canton Medical School. After opening a private practice in England, Rowan moved to Canada to run a three-year program in herbal sciences in Vancouver. Rowan is responsible for elevating the study of natural medicine in Canada and the United States. He has worked as a consultant with companies in the UK and in Canada, advising on them on elements of natural medicine and developing new products for the market. Rowan says, “Original thinking happens when you step off the rail and start solving problems. What Humn Pharmaceuticals is doing is producing a range of high performance, completely safe, functional medicinal products that will help people worldwide.” Rowan serves as an advisor and supervisor of research within Humn Pharmaceuticals, as well as advisor on ingredients and the development of new products.

Greg Herron


Executive Director UK

A highly experienced international sales and marketing executive. He has highly developed relationships in his area of responsibility that have been nurtured during his years of involvement with global sales activities. He has also gained strong business and communication skills directly related to his operational functionality. He has lived and worked in many overseas locations.

Blabbly LTD


Brand Marketing Management 

The creative team at Blabbly Ltd. believes that truly impactful brands inspire their audiences to action, to dream, to change; they leave an impression on their audiences and wield genuine influence. HUMN as a belief-led company echos Blabbly's operating philosophies and passion to inspire deeper emotional engagement among consumers and truly make a difference in the world.

Rodger Lundon


Manager Client Services

Has an extensive background in retailing and business administration including inventory management, human resources, supply chain functions in addition to back-office administration systems.

Chris Moss


Director of Special Projects

Chris Moss

Chris Moss is an accomplished medical, pharma, and surgical representative with a longstanding track record of success including recognition for highest national sales and profit performance. Chris has developed and maintained an expansive network over his 40-year tenure with contacts and working relationships across the medical, surgical, and pharma fields, including a diverse network of customers and end-users, medical and surgical specialists, buyers, managers, key decision-makers in buying groups and health regulatory and legislative authorities.

His exceptional knowledge of a wide spectrum of products in surgical, medical, and OTC Pharma fields, including product applications and functions have won Chris numerous sales distinctions and top Canadian performer awards, attaining "lion's share" of his market. Chris has always put the customer first and foremost, and after many years of problem-solving, he became the trusted advisor within his territory. He is a strong believer in collaboration and teamwork; a foundation that was built on his athletic background tracing back to highschool and university, which in turn has helped him develop strong bonds with his working associates over the years. HUMN is now his team and with Chris' long-standing reputation, distinguished sales proficiencies and capacity to network and to bring people together has and will continue to add value to the dynamic management group at Humn Pharmaceuticals

Michael van der Horn


Manager Information Technology

Owner and Director of an IT Services company providing both software solutions and management services. In the past 15 years, he has provided IT services in the healthcare, finance and insurance industries.

Rowan Hamilton D.Phyt. DTCM


Director of Research and Education 

Rowan Hamilton is a Medical Herbalist and Doctor of TCM, having studied in England and China at the Canton Medical School. After opening a private practice in England, Rowan moved to Canada to run a three-year program in herbal sciences in Vancouver. Rowan is responsible for elevating the study of natural medicine in Canada and the United States. He has worked as a consultant with companies in the UK and in Canada, advising on them on elements of natural medicine and developing new products for the market. Rowan says, “Original thinking happens when you step off the rail and start solving problems. What Humn Pharmaceuticals is doing is producing a range of high performance, completely safe, functional medicinal products that will help people worldwide.” Rowan serves as an advisor and supervisor of research within Humn Pharmaceuticals, as well as advisor on ingredients and the development of new products.

Greg Herron


Executive Director UK

A highly experienced international sales and marketing executive. He has highly developed relationships in his area of responsibility that have been nurtured during his years of involvement with global sales activities. He has also gained strong business and communication skills directly related to his operational functionality. He has lived and worked in many overseas locations.

Blabbly LTD


Brand Marketing Management 

The creative team at Blabbly Ltd. believes that truly impactful brands inspire their audiences to action, to dream, to change; they leave an impression on their audiences and wield genuine influence. HUMN as a belief-led company echos Blabbly's operating philosophies and passion to inspire deeper emotional engagement among consumers and truly make a difference in the world.

Blair J. McInnes


Founder and Chairman of the Board

Blair McInnes has as spent several decades founding, running, and investing in companies that addressed an unfulfilled need with a clear and executable vision of their market niche. As president of a Canadian company, he expanded its market into the United States where it established itself as a multi-million-dollar enterprise. McInnes also negotiated the acquisition of a Canadian IT company and brought it into the US public market to expand both the company’s access to capital as well as its shareholder value. Eight years ago, he saw what he believed to be a unique opportunity in the pharmaceutical marketplace and provided the seed capital to found Humn Pharmaceuticals. Fueled by his belief that everyone deserves affordable natural products that are safe and perform as intended, he assembled experienced management and research teams and focused the company to develop formulations that filled this void, eventually expanding these products beyond Canada and into the United States and Europe. Working with his research teams, Blair continues to help address the development of products that satisfy the demand for products in areas lacking solutions. In parallel, he coordinates with his sales team to establish distribution channels for these products.

Art Pemberton


President And Chief Operating Officer

Art Pemberton has a successful 30+ year record of strategic, executive / senior management, and consulting roles with both private and public international corporations. He’s been regarded as the driving force in the creation of dominant and vertically integrated organizations for two of Canada's leading companies which marketed their products internationally. As the president, CEO, and board member of a $500 million manufacturing, wholesale, and retail conglomerate with over 5,000 employees, Art was involved in the retail, distribution and manufacturing aspects of the business with strategic input to operations, information technology, human resources, legal, and finance thereby substantially driving sales and profitability. He is also a recognized expert in mergers, acquisitions, and turnarounds. As the President / COO of a retail chain with five operating divisions within North America, Art negotiated the acquisition of a retail chain out of bankruptcy and within three months restructured the company to such an extent that it was able to reopen sixty-four stores on a single day. The speed of implementation, along with the financial and business expertise displayed in this restructuring, enabled the acquiring company to enhance its profitability thereby increasing profits, through both savings and revenue, by millions annually. Art is focused on overseeing the strategic aspects of product development, expanding Humn Pharmaceuticals through mergers and acquisitions, and creating the infrastructure that will allow it to function as a public company.

Brian Herron


Managing Director, UK 

Has over 30 years of experience in distribution logistics within the pharmaceutical and health products industry, primarily in Europe. His responsibilities entailed fleet management, warehousing, shipping, customer relationship management. Brian brings more than three decades of experience to Humn Pharmaceuticals with a focus on creating a seamless and dynamic customer distribution network.

Connie Clerici


Director Designate 

President and CEO, Closing the Gap Healthcare Group, with over 30 years of experience in the health care field and currently employing over 750 healthcare professionals. Ms. Clerici brings a unique perspective to potential markets and product development. Ms. Clerici was an Advisory Board member in 2011 for Women of Influence and a 2011 Entrepreneurship Council member with the Richard Ivey School of Business.

Gail Halko


Director Designate 

Ms. Halko is the founder and owner of Grand Medicine Health Services and COO of the Grand Medicine Group of Companies. Following her experience with an International Pharmaceutical company and an owner-operator of a community Pharmacy, Gail founded Grand Medicine in 1999 with the goal of redefining a pharmacy’s interactions with clients. Her vision was to build a service-based model aimed at meeting the specific needs of clients and explicitly move away from the traditional commodity-based model of the industry. As a testament to successfully realizing this vision, Grand Medicine was awarded the prestigious Canadian Pharmaceutical Associations’ Patient Care Achievement Award for Innovation in 2012.

Blair J. McInnes


Founder and Chairman of the Board

Blair McInnes has as spent several decades founding, running, and investing in companies that addressed an unfulfilled need with a clear and executable vision of their market niche. As president of a Canadian company, he expanded its market into the United States where it established itself as a multi-million-dollar enterprise. McInnes also negotiated the acquisition of a Canadian IT company and brought it into the US public market to expand both the company’s access to capital as well as its shareholder value. Eight years ago, he saw what he believed to be a unique opportunity in the pharmaceutical marketplace and provided the seed capital to found Humn Pharmaceuticals. Fueled by his belief that everyone deserves affordable natural products that are safe and perform as intended, he assembled experienced management and research teams and focused the company to develop formulations that filled this void, eventually expanding these products beyond Canada and into the United States and Europe. Working with his research teams, Blair continues to help address the development of products that satisfy the demand for products in areas lacking solutions. In parallel, he coordinates with his sales team to establish distribution channels for these products.

Art Pemberton


President And Chief Operating Officer

Art Pemberton has a successful 30+ year record of strategic, executive / senior management, and consulting roles with both private and public international corporations. He’s been regarded as the driving force in the creation of dominant and vertically integrated organizations for two of Canada's leading companies which marketed their products internationally. As the president, CEO, and board member of a $500 million manufacturing, wholesale, and retail conglomerate with over 5,000 employees, Art was involved in the retail, distribution and manufacturing aspects of the business with strategic input to operations, information technology, human resources, legal, and finance thereby substantially driving sales and profitability. He is also a recognized expert in mergers, acquisitions, and turnarounds. As the President / COO of a retail chain with five operating divisions within North America, Art negotiated the acquisition of a retail chain out of bankruptcy and within three months restructured the company to such an extent that it was able to reopen sixty-four stores on a single day. The speed of implementation, along with the financial and business expertise displayed in this restructuring, enabled the acquiring company to enhance its profitability thereby increasing profits, through both savings and revenue, by millions annually. Art is focused on overseeing the strategic aspects of product development, expanding Humn Pharmaceuticals through mergers and acquisitions, and creating the infrastructure that will allow it to function as a public company.

Brian Herron


Managing Director, UK 

Has over 30 years of experience in distribution logistics within the pharmaceutical and health products industry, primarily in Europe. His responsibilities entailed fleet management, warehousing, shipping, customer relationship management. Brian brings more than three decades of experience to Humn Pharmaceuticals with a focus on creating a seamless and dynamic customer distribution network.

Connie Clerici


Director Designate 

President and CEO, Closing the Gap Healthcare Group, with over 30 years of experience in the health care field and currently employing over 750 healthcare professionals. Ms. Clerici brings a unique perspective to potential markets and product development. Ms. Clerici was an Advisory Board member in 2011 for Women of Influence and a 2011 Entrepreneurship Council member with the Richard Ivey School of Business.

Gail Halko


Director Designate 

Ms. Halko is the founder and owner of Grand Medicine Health Services and COO of the Grand Medicine Group of Companies. Following her experience with an International Pharmaceutical company and an owner-operator of a community Pharmacy, Gail founded Grand Medicine in 1999 with the goal of redefining a pharmacy’s interactions with clients. Her vision was to build a service-based model aimed at meeting the specific needs of clients and explicitly move away from the traditional commodity-based model of the industry. As a testament to successfully realizing this vision, Grand Medicine was awarded the prestigious Canadian Pharmaceutical Associations’ Patient Care Achievement Award for Innovation in 2012.

Gail Halko


Chief Executive Officer of SpiritRx Services

gail-head-2018

Gail Halko is the new Chief Executive Officer of SpiritRx Services. From 2003 until March of 2019 Gail was a shareholder and Director of Operations with Grand Medicine Health Services Group of Companies. A graduate from the University of Manitoba, Gail has always worked on the business side of healthcare including five years with an International Pharmaceutical company. Prior to joining Grand Medicine, Gail owned and operated a community Pharmacy.

In March of 2019 Spirit Healthcare Group, owned by the New Tribal Councils Investment Group of Manitoba achieved economic reconciliation for their shareholders - the seven Tribal Councils of Manitoba. They acquired Grand Medicine Health Services, bringing home ownership to the communities the company serves. In October of 2019 the company’s name was changed to SpiritRx Services.

SpiritRx Services is one of the largest First Nation owned healthcare companies in Canada. It offers multi-faceted healthcare services including pharmacy, medical supply, drug wholesale and diabetes education and it has been recognized for its excellence with multiple industry awards for innovation. Gail’s role has focused on the economics and logistics of providing high quality pharmacy services in a distance care environment, as well as drug formulary navigation at the Federal and Provincial level. In particular, Gail’s expertise lies in that space where First Nation peoples move from Provincial health programming to Federal health programming, primarily focused on people living in rural and remote communities. She has the depth and breadth of expertise in Federal First Nations drug plan management, the limitations of that, and the resulting impacts on provincial budgets.

For the last 10 years, The Grand Medicine Group also included Grand Medicine Pharmacy, a pharmacy in rural Manitoba that was also acquired by SpiritRx and continues to own Grand Medicine Health Sciences Pharmacy, an outpatient pharmacy located in the largest tertiary care hospital between Thunder Bay and Edmonton . It was this experience that provided a front row seat in seeing the needs and opportunities for high quality pharmacy care.

In 2016, Gail worked with a group out of Vancouver to develop a pilot project for patients wanting to access medicinal cannabis. Within this Pilot, Gail developed a cannabis service model of education and support similar to other healthcare based patient education models. Medicinal cannabis has traditionally been kept at the edges of healthcare but with the Federal government mandate to legalize cannabis, she sought to develop a healthcare model distinctly defined and separate from a recreational one. In developing this Centre Gail has become an expert in medicinal cannabis with knowledge ranging from Licensed Producers, cannabis components, distribution channels, the current legal framework and future frameworks being explored by the Federal government.

Charles E. Pappas, MD


Technical Board

Dr. Pappas, following 20 years of practice of plastic surgery, became the founder of the Aesthetic Health Care Center in 1997. A native of the Philadelphia area and after graduation from the University of Pennsylvania he completed residencies and fellowships in general surgery, plastic surgery and transplant surgery at The Johns Hopkins Hospital, Temple University Hospitals, and Harvard hospitals, Massachusetts General and the Peter Bent Brigham Hospital.

He became Chairman of the Department of Plastic Surgery at Temple University in 1978, and continues his academic appointment today as Associate Professor of Surgery. Dr. Pappas entered full-time private practice in Chestnut Hill, PA in 1980 while maintaining teaching appointments for residency training at Temple and Jefferson Hospitals, and served as the Chief of the Plastic Surgery divisions at both Chestnut Hill Hospital and Roxborough Memorial Hospitals. He lectures frequently nationally and internationally on subjects relating to cosmetic and reconstructive surgery.

Dr. Pappas is a member of Who’s Who in America, and was included in the Commemorative issue of Who’s Who in Medicine and Science.

Recognizing the need to strive for the highest standards in aesthetic plastic surgical care on an ambulatory basis, he built the Fort Washington Surgery Center, which subsequently received Pennsylvania licensure, JCAHO and Medicare certification.  By merging selective surgical practices and incorporating an ambulatory surgical facility, he helped to form the Centers of Excellence of Aesthetic Health Care. This Center became the model for the development of other centers.

Integral to the success of these Centers, Dr. Pappas identified and preserved the core medical interests of the member surgeons, eliminated the redundancy in clerical and support personnel, standardized information and data management systems, and initiated marketing programs to generate new and stronger patient referrals. Along with co-marketing programs with correlative specialties in dermatology, ophthalmology, and otolaryngology, he established network feeder sources from regional beauty centers, day spas, and salons. These efforts significantly reduced overhead, increased the gross revenue and generated significant ‘same-store growth’ from year to year, while the surgeons enjoyed improved patient care and greater net revenues.

At present, Dr. Pappas serves a consulting role in the development and growth of The Aesthetic Health Care Center in Fort Washington and other cities. He was instrumental in developing the Centers in Jacksonville, Miami, Philadelphia, Ft. Washington, New Brunswick, and Ft. Myers.

Dr Jason Crosby – Orthopedic Surgeon


Technical Board

Dr. Crosby was born and raised in Winnipeg Manitoba, He obtained his Bachelor of Science, undergraduate MD, and Orthopedic residency training at the University of Manitoba. He completed his Royal College of Physicians and Surgeons of Canada certification in Orthopedics in 2007. Subsequent sub-specialization fellowships completed in the Division of Arthroscopy and Athletic Injuries, UBC, Vancouver, British Columbia, 2008; Lower Limb Fellowship in Trauma and Orthopedics, Norwich and Norfolk Hospital, Norwich, England, 2008; and Hip and Knee Arthroplasty and Reconstruction, Prince of Wales Hospital, Sydney, Australia, 2009.

Dr. Crosby’s practice in Orthopedic surgery began September 2009 out of the Manitoba Clinic and is presently affiliated with the Grace Hospital and Pan Am Clinic where his practice is focused jointly on elective arthroplasty (joint replacement) and sports arthroscopy. Dr. Crosby is also one of a 10-member trauma orthopedic call team at the Grace hospital.

With the addition of colleagues at the clinic, in September 2018, Dr. Crosby and three partners co-founded their present clinic: Fort Whyte Orthopedics. They have added an additional surgeon associate and grown from three to six full-time staff last year. They aspire to evolve and expand this clinic into a free-standing fully integrated musculoskeletal health facility offering Minor Injury, Sports Medicine, Orthopedic Surgery supplemented with affiliated support infrastructure, ultimately poised to offer private care service and possibly surgical suites.

Dr. Crosby enjoys embracing the unique opportunity, and as such, is a proud member of a locally organized medical mission team of 60 healthcare professionals under the umbrella group Operation Walk. Annually, they plan, fundraise, and execute a one-week mission of providing joint replacements to the people of Nicaragua who would otherwise never have such an opportunity to restore their mobility.

Dr. Crosby is a strong addition to the Technical Advisory Board of Humn Pharmaceuticals with his medical background and broad knowledge base. He holds a diverse skill set highlighted by being a team player, possessing leadership qualities, good time management, and written and verbal communication. He is a passionate, dedicated, reliable, insightful, prepared, and organized individual who enjoys new challenges and lifelong learning.

Bankers Capital International


Technical Board

Bankers Capital International has been appointed as HUMN’s Investment Banker on our Advisory Board. Under the leadership of Todd DeMatteo, Founder & Senior Executive Director, Bankers Capital International (“BCI”) is a boutique investment bank, headquartered in New York City, focused on institutional clients and Global markets. They are dedicated to helping clients identify and leverage business opportunities, such as M&As, capital raises, restructuring, turnarounds and strategic planning, serving the global market of North America, Europe, Asia and Russia. For more information please go to bankerscapitalinternational.com

Ken Carroll


Technical Board

Ken Carroll received his degree in law from Robson Hall, University of Manitoba in 1978 and was active in the practice of law until 2020 and only recently has withdrawn from the practice of law to become more directly involved in business activities.  He has served as legal counsel to local, national and international clients, primarily focusing on corporate law, commercial law and real estate law.

Through his years of practice, Ken has worked closely with many start-up companies in various fields, helping to organize their businesses from the ground up, to become successful ventures.  He brings much knowledge and experience in law, organizational structure, due diligence and related business matters.  He is also effective in assessing new business opportunities and provides meaningful contributions to business relationships, negotiations, corporate organizations and business strategies to help bring new enterprises to market.

Adam Topp


Technical Board

Former Director of Operations for the Winnipeg Health Sciences Center, an operating division of the Winnipeg Regional Health Authority. Mr. Topp has been a principal consultant on numerous complex high-level healthcare tasks and has published several industry related documents.

Adam Topp


Technical Board

Former Director of Operations for the Winnipeg Health Sciences Center, an operating division of the Winnipeg Regional Health Authority. Mr. Topp has been a principal consultant on numerous complex high-level healthcare tasks and has published several industry related documents.

Adam Topp


Junta técnica

Ex Director de Operaciones del Centro de Ciencias de la Salud de Winnipeg, una división operativa de la Autoridad de Salud Regional de Winnipeg. El Sr. Topp ha sido consultor principal en numerosas tareas complejas de alto nivel relacionadas con la atención médica y ha publicado varios documentos relacionados con la industria.

Charles E. Pappas, MD


Technical Board

Dr. Pappas, following 20 years of practice of plastic surgery, became the founder of the Aesthetic Health Care Center in 1997. A native of the Philadelphia area and after graduation from the University of Pennsylvania he completed residencies and fellowships in general surgery, plastic surgery and transplant surgery at The Johns Hopkins Hospital, Temple University Hospitals, and Harvard hospitals, Massachusetts General and the Peter Bent Brigham Hospital.

He became Chairman of the Department of Plastic Surgery at Temple University in 1978, and continues his academic appointment today as Associate Professor of Surgery. Dr. Pappas entered full-time private practice in Chestnut Hill, PA in 1980 while maintaining teaching appointments for residency training at Temple and Jefferson Hospitals, and served as the Chief of the Plastic Surgery divisions at both Chestnut Hill Hospital and Roxborough Memorial Hospitals. He lectures frequently nationally and internationally on subjects relating to cosmetic and reconstructive surgery.

Dr. Pappas is a member of Who’s Who in America, and was included in the Commemorative issue of Who’s Who in Medicine and Science.

Recognizing the need to strive for the highest standards in aesthetic plastic surgical care on an ambulatory basis, he built the Fort Washington Surgery Center, which subsequently received Pennsylvania licensure, JCAHO and Medicare certification.  By merging selective surgical practices and incorporating an ambulatory surgical facility, he helped to form the Centers of Excellence of Aesthetic Health Care. This Center became the model for the development of other centers.

Integral to the success of these Centers, Dr. Pappas identified and preserved the core medical interests of the member surgeons, eliminated the redundancy in clerical and support personnel, standardized information and data management systems, and initiated marketing programs to generate new and stronger patient referrals. Along with co-marketing programs with correlative specialties in dermatology, ophthalmology, and otolaryngology, he established network feeder sources from regional beauty centers, day spas, and salons. These efforts significantly reduced overhead, increased the gross revenue and generated significant ‘same-store growth’ from year to year, while the surgeons enjoyed improved patient care and greater net revenues.

At present, Dr. Pappas serves a consulting role in the development and growth of The Aesthetic Health Care Center in Fort Washington and other cities. He was instrumental in developing the Centers in Jacksonville, Miami, Philadelphia, Ft. Washington, New Brunswick, and Ft. Myers.

Dr Jason Crosby – Orthopedic Surgeon


Technical Board

Dr. Crosby was born and raised in Winnipeg Manitoba, He obtained his Bachelor of Science, undergraduate MD, and Orthopedic residency training at the University of Manitoba. He completed his Royal College of Physicians and Surgeons of Canada certification in Orthopedics in 2007. Subsequent sub-specialization fellowships completed in the Division of Arthroscopy and Athletic Injuries, UBC, Vancouver, British Columbia, 2008; Lower Limb Fellowship in Trauma and Orthopedics, Norwich and Norfolk Hospital, Norwich, England, 2008; and Hip and Knee Arthroplasty and Reconstruction, Prince of Wales Hospital, Sydney, Australia, 2009.

Dr. Crosby’s practice in Orthopedic surgery began September 2009 out of the Manitoba Clinic and is presently affiliated with the Grace Hospital and Pan Am Clinic where his practice is focused jointly on elective arthroplasty (joint replacement) and sports arthroscopy. Dr. Crosby is also one of a 10-member trauma orthopedic call team at the Grace hospital.

With the addition of colleagues at the clinic, in September 2018, Dr. Crosby and three partners co-founded their present clinic: Fort Whyte Orthopedics. They have added an additional surgeon associate and grown from three to six full-time staff last year. They aspire to evolve and expand this clinic into a free-standing fully integrated musculoskeletal health facility offering Minor Injury, Sports Medicine, Orthopedic Surgery supplemented with affiliated support infrastructure, ultimately poised to offer private care service and possibly surgical suites.

Dr. Crosby enjoys embracing the unique opportunity, and as such, is a proud member of a locally organized medical mission team of 60 healthcare professionals under the umbrella group Operation Walk. Annually, they plan, fundraise, and execute a one-week mission of providing joint replacements to the people of Nicaragua who would otherwise never have such an opportunity to restore their mobility.

Dr. Crosby is a strong addition to the Technical Advisory Board of Humn Pharmaceuticals with his medical background and broad knowledge base. He holds a diverse skill set highlighted by being a team player, possessing leadership qualities, good time management, and written and verbal communication. He is a passionate, dedicated, reliable, insightful, prepared, and organized individual who enjoys new challenges and lifelong learning.

Bankers Capital International


Technical Board

Bankers Capital International has been appointed as HUMN’s Investment Banker on our Advisory Board. Under the leadership of Todd DeMatteo, Founder & Senior Executive Director, Bankers Capital International (“BCI”) is a boutique investment bank, headquartered in New York City, focused on institutional clients and Global markets. They are dedicated to helping clients identify and leverage business opportunities, such as M&As, capital raises, restructuring, turnarounds and strategic planning, serving the global market of North America, Europe, Asia and Russia. For more information please go to bankerscapitalinternational.com

Ken Carroll


Technical Board

Ken Carroll received his degree in law from Robson Hall, University of Manitoba in 1978 and was active in the practice of law until 2020 and only recently has withdrawn from the practice of law to become more directly involved in business activities.  He has served as legal counsel to local, national and international clients, primarily focusing on corporate law, commercial law and real estate law.

Through his years of practice, Ken has worked closely with many start-up companies in various fields, helping to organize their businesses from the ground up, to become successful ventures.  He brings much knowledge and experience in law, organizational structure, due diligence and related business matters.  He is also effective in assessing new business opportunities and provides meaningful contributions to business relationships, negotiations, corporate organizations and business strategies to help bring new enterprises to market.